当前位置:首页 - 行情中心 - 仟源医药(300254) - 财务分析 - 现金流量表

仟源医药

(300254)

  

流通市值:22.73亿  总市值:25.94亿
流通股本:2.24亿   总股本:2.56亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金567,545,035.96366,156,378.93180,265,349.65784,575,533.89
  收到的税费返还1,086,813.441,086,813.441,086,813.44143,992.9
  收到其他与经营活动有关的现金17,271,486.5413,543,051.588,463,432.6556,699,891.03
  经营活动现金流入小计585,903,335.94380,786,243.95189,815,595.74841,419,417.82
  购买商品、接受劳务支付的现金69,952,004.4947,287,758.5923,228,679.48158,459,857.21
  支付给职工以及为职工支付的现金129,851,459.8894,050,773.3150,088,819.64173,544,513.06
  支付的各项税费92,437,962.2861,742,598.4724,197,896.4996,672,359.17
  支付其他与经营活动有关的现金218,250,055.43155,221,703.0287,142,655.12341,802,084.22
  经营活动现金流出小计510,491,482.08358,302,833.39184,658,050.73770,478,813.66
  经营活动产生的现金流量净额75,411,853.8622,483,410.565,157,545.0170,940,604.16
二、投资活动产生的现金流量:
  收回投资收到的现金---390,817.63
  取得投资收益收到的现金---2,827,669.48
  处置固定资产、无形资产和其他长期资产收回的现金净额121,97957,4803,200212,288
  处置子公司及其他营业单位收到的现金净额---1,630,157.12
  收到的其他与投资活动有关的现金---1,400,000
  投资活动现金流入小计121,97957,4803,2006,460,932.23
  购建固定资产、无形资产和其他长期资产支付的现金28,643,263.6618,275,121.469,287,259.7251,500,333.75
  投资支付的现金60,289,231.0460,289,231.0460,289,231.04203,230,768.96
  投资活动现金流出小计88,932,494.778,564,352.569,576,490.76254,731,102.71
  投资活动产生的现金流量净额-88,810,515.7-78,506,872.5-69,573,290.76-248,270,170.48
三、筹资活动产生的现金流量:
  吸收投资收到的现金43,960,000--33,346,500
  取得借款收到的现金150,800,00095,000,00083,000,000321,624,008
  收到其他与筹资活动有关的现金48,000,000--1,800,000
  筹资活动现金流入小计242,760,00095,000,00083,000,000356,770,508
  偿还债务支付的现金223,600,00077,300,00070,000,000121,751,000
  分配股利、利润或偿付利息支付的现金15,152,157.7910,163,757.835,001,886.4712,321,406.35
  支付其他与筹资活动有关的现金11,151,388.458,622,4256,080,98027,854,062.35
  筹资活动现金流出小计249,903,546.2496,086,182.8381,082,866.47161,926,468.7
  筹资活动产生的现金流量净额-7,143,546.24-1,086,182.831,917,133.53194,844,039.3
五、现金及现金等价物净增加额-20,542,208.08-57,109,644.77-62,498,612.2217,514,472.98
  加:期初现金及现金等价物余额149,507,040.96149,507,040.96149,507,040.96131,992,567.98
  期末现金及现金等价物余额128,964,832.8892,397,396.1987,008,428.74149,507,040.96
补充资料:
  净利润-16,333,500.92-74,759,548.26
  资产减值准备--1,421,832.58-13,137,532.84
  固定资产和投资性房地产折旧-17,667,451.27-35,113,827.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-17,667,451.27-35,113,827.88
  无形资产摊销-8,666,376.14-16,391,912.32
  长期待摊费用摊销-584,155.89-1,023,541.51
  处置固定资产、无形资产和其他长期资产的损失--7,895,012.66--7,507,360.71
  固定资产报废损失-131,459.11-1,405,508.76
  财务费用-11,923,412.63-16,976,345.71
  投资损失--113,156.56--4,544,279.82
  递延所得税-1,836,311.58--9,914,010.04
  其中:递延所得税资产减少-3,780,677.38--8,001,652.84
    递延所得税负债增加--1,944,365.8--1,912,357.2
  存货的减少--16,245,751.85--28,389,460.67
  经营性应收项目的减少--38,335,457.27--71,137,900.38
  经营性应付项目的增加-17,982,630.83-13,403,710.19
  其他-7,641,952.53-13,480,477.48
  不涉及现金收支的投资和筹资活动金额其他项目---20,919,180.52
  现金的期末余额-92,397,396.19-149,507,040.96
  减:现金的期初余额-149,507,040.96-131,992,567.98
  现金及现金等价物的净增加额--57,109,644.77-17,514,472.98
公告日期2025-10-302025-08-262025-04-192025-04-15
审计意见(境内)标准无保留意见
TOP↑